Endologix: 3Q Earnings Snapshot

November 6, 2019 GMT

IRVINE, Calif. (AP) _ Endologix Inc. (ELGX) on Wednesday reported a loss of $7.8 million in its third quarter.

The Irvine, California-based company said it had a loss of 40 cents per share. Losses, adjusted for non-recurring gains, came to 54 cents per share.

The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 64 cents per share.

The medical device company posted revenue of $35.8 million in the period, which also topped Street forecasts. Five analysts surveyed by Zacks expected $35.3 million.

For the current quarter ending in December, Endologix said it expects revenue in the range of $32.5 million to $35.5 million.

In the final minutes of trading on Wednesday, the company’s shares hit $2.65. A year ago, they were trading at $13.70.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ELGX at https://www.zacks.com/ap/ELGX